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Summary Epilepsy is an important problem in neurological disorders. The common
features of all types of epilepsy are the synchronized and uncontrolled discharges of
nerve cell assemblies. Recent studies claimed that gap junctions have a critical role in
epileptic neuronal events. The aim of present study is to investigate the effects of
connexin36 (Cx36) channel blocker quinine on penicillin-induced experimental epi-
lepsy. For this purpose, 4 months old male Wistar rats were used in the present study.
Permanent screw electrodes allowing EEG monitoring from conscious animals and
permanent cannula providing the administration of the substances to the brain
ventricle were placed into the cranium of rats under general anesthesia. At the
end of the postoperative recovery period, epileptiform activity was generated by
injecting 300 IU crystallized penicillin through the ventricular cannula. When the
epileptiform activity, monitored from a digital recording system, reached maximal
frequency and amplitude, quinine (200, 400 or 1000 nmol) was administered similar to
penicillin. Effects of quinine on epileptiform activity were assessed by both electro-
physiological and behavioral analysis. Quinine suppressed epileptiform activity by
decreasing the amplitude and frequency of epileptiform spikes and by attenuating the
epileptiform behavior. The outcomes of this study suggest that the blockade of Cx36
channels may contribute to the amelioration of epileptic activity.
# 2006 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.Introduction
Epilepsy is one of the most widespread neurological
disorders in the world population and current phar-
macological therapies remain insufficient to pre-
vent epileptic seizures completely. The common* Corresponding author. Tel.: +90 362 3121919/3065;
fax: +90 362 4576041.
E-mail address: mehmetob@omu.edu.tr (M.O¨. Bostanci).
1059-1311/$ — see front matter # 2006 British Epilepsy Association
doi:10.1016/j.seizure.2006.11.007features of all types of epilepsy are the synchronized
and uncontrolled discharges of nerve cell assem-
blies. During epileptic seizures, the physiological
balance between excitation and inhibition is altered
towards the excitation.
The reason for the pathologically synchronized
discharges of the neuron is not exactly known yet.
The hypothesis of strengthened interconnections
between neurons through electrical synapses,
as a possible mechanism underlying neuronal. Published by Elsevier Ltd. All rights reserved.
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duced about 20 years ago.1 It has been recently
proposed that neuronal gap junctions can represent
a potential target for anticonvulsant therapy. The
blockade of gap junction communication has been
shown to reduce seizures in different epilepsy mod-
els, both in vitro2—4 and in vivo5,6 epilepsy models.
Quinine, known to be antimalarial drug, has the
ability to block Cx36 and Cx50 junctional currents in
a reversible and concentration-dependent manner.7
Cx36 is the principal neuronal connexin in the adult
brain,8—11 whereas Cx50 is expressed in the lens.12
Studies have shown that Cx36 is expressed in g-
aminobutyric acid (GABA)ergic interneurons in sev-
eral brain regions13 and analysis of Cx36 knock-out
mice have confirmed its role in interneuronal cou-
pling.14—16 In old papers, it has been reported that
quinine treatment could be used in children against
epilepsy.17,18 Recent studies also demonstrate that
quinine has anticonvulsive effects in different epi-
lepsy models.19—21
The effects of quinine have been described in the
4-aminopyridine-induced in vivo epilepsy model,21
but there is no other in vivo study regarding the
effects of quinine on experimental epilepsy models.
Penicillin may induce seizures in susceptible
patients and it is structurally similar to GABA
antagonist bicuculline. In the present study, we
aimed to investigate whether quinine has anticon-
vulsant effects on penicillin-induced epileptiform
activity in conscious rats by using behavioral and
electrophysiological recording methods.Materials and methods
Animals
Four-month-old male Wistar rats weighing
220  30 g were used. Rats were kept in heat-regu-
lated rooms, on a 12-h:12-h day/night cycle, and
given as much food and water as needed. All experi-
mental procedures were carried out according to
the guidelines of European Community Council for
experimental animal care.
Operation
The animals were anesthetized with ketamine
hydrochloride (100 mg/kg, i.p.) and placed in a
stereotaxic apparatus (David Kopf, MI). After mid-
line incision, two stainless steel screw electrodes
(1 mm diameter) were placed over the left frontal
and parietal cortex. The reference electrode was
placed at the center of the forehead, and all elec-
trodes were attached to a connecting socket. Aguide cannula (26-gauge) was implanted stereotaxi-
cally into the right lateral cerebral ventricle. The
coordinates for cannula were: 0.6 mm posterior to
Bregma, 2.0 mm lateral to the midline and 4.2 mm
below the surface of the skull.22 Then the electrodes
and guide cannula were fixed using cold dental
acrylic. Housed individually animals were allowed
at least a week to recover from surgery. For the
intracerebroventricular (i.c.v.) administration of
drugs, animals were gently hand-restrained and
drug infusions were made using injector cannula
connected by a polyethylene tube to a 10 ml Hamil-
ton (Type 701N) syringe (infusion rate 1 ml/min).Experimental design
One week after the surgical procedure, rats were
transferred to the observation cage. Fully conscious
animals were connected to a computerized EEG
recording system (PowerLab/4SP, AD Instruments)
by an isolated flexible cable. After the rats habitu-
ated to the experimental and recording conditions,
the baseline EEG activity was recorded for 30 min.
Subsequently, penicillin G potassium (300 IU, in
3 ml) was injected into brain ventricle. Behavioral
changes were noted and EEG was recorded for an
additional 3 h. In order to investigate the effects of
penicillin, recording continued until the end of
epileptic activity in only penicillin group rats. It
was found that epileptiform activity reached max-
imum frequency (182  35 min1) and amplitude
(918  96 mV) within 45 min and this maximum
effect continued for 114  12 min (n = 7). There-
fore, in order to investigate the effects of quinine
on epileptiform activity, the 114-min period in
which penicillin had maximum effect was used.
Epileptic behaviors were scored according to a
modified version of scale used by Patel et al.23: no
response, 0; twitching of face and ear, fictive
scratching, 1; myoclonic twitching and tremor, 2;
bilateral forelimb clonus, 3; tonic-clonic seizure, 4;
tonic-clonic seizure without postural control, 5.
Rats were divided into four groups: control
(n = 7), quinine (n = 15), penicillin (n = 7) and peni-
cillin + quinine (n = 21). Rats in the control group
received only vehicle solution (i.c.v.) while animals
in treatment groups received various doses (200,
400 and 1000 nmol, i.c.v.) of quinine after 1 h peni-
cillin injection. In order to find out whether quinine
changes baseline EEG activity, rats in quinine group
were given quinine alone (200, 400 and 1000 nmol,
i.c.v.). Quinine was dissolved in 5% dimethylsulfox-
ide (DMSO) solution. In this study, the drugs were
administered to the brain ventricle only once in 3 ml
volume.
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cannula was visually confirmed by 2% methylene
blue infusion through the i.c.v. cannula after the
animals were given a lethal dose of anesthetic.Statistical analysis
Electrophysiological data were analyzed using Chart
program (Version 5.2). Spike frequency and ampli-
tude value were expressed as a percentage of con-
trol rates. Data obtained from recordings during the
5-min period prior to drug injections were assumed
as control data of spike frequency and amplitude
values. After the injections of the drugs, data were
calculated in 5-min periods during 2 h. Then these
data were compared to control data.
All statistical procedures were performed using
SPSS (12.0) statistical software package. Values are
expressed as means  S.E.M. The effects of the
drugs on spike frequency and amplitude were sta-
tistically evaluated by paired t-test, and analysis of
variance (ANOVA) was used for differences between
groups. Behavioral scores were analyzed by Wil-
coxon matched-pairs signed-ranks test, and the
Mann—Whitney U-test was used to determine
whether there were differences between doses.Drugs
Penicillin, quinine, ketamine hydrochloride and
DMSO were purchased from Sigma Chemical Co.
(St. Louis, MO, USA).Results
Intracerebroventricular injection of 200 nmol
(n = 5), 400 nmol (n = 5) and 1000 nmol (n = 5) qui-
nine did not cause any change of the frequency or
amplitude of EEG activity in respect to control
baseline in non-penicillin injected animals (Fig. 1A).
Penicillin induced an epileptiform EEG activity
characterized by biphasic (positive and negative)
spikes and spike-wave complexes. Appearance of
epileptic discharges started 50  14 s after i.c.v.
crystallized penicillin (300 IU, 3 ml) administration
(n = 7) (Fig. 1B). Spike frequency and amplitude of
epileptiform activity reached the maximum level at
36  9 min, began to decline at 150  18 min and
disappeared at 227  23 min. It was also observed
that animals had behavioral tonic-clonic seizure
26  7 min after penicillin administration.
Themean spike frequencywas182  35 min1 and
the mean spike amplitude was 918  96 mV beforethe quinine injection (n = 21). In penicillin + quinine
group, spike frequencies were significantly
decreased 17  5, 12  3 and 7  4 min after injec-
tion of 200 nmol (n = 7), 400 nmol (n = 7) and
1000 nmol (n = 7) doses of quinine, respectively
(p < 0.05, Fig. 2). Spike amplitudes were also sig-
nificantly reduced by 200, 400 and 1000 nmol quinine
administration after 21  6, 11  4 and 5  3 min,
respectively (p < 0.05, Fig. 3). Vehicle solution did
affect neither frequency nor amplitude of epilepti-
form discharges induced by penicillin (p > 0.05,
Fig. 1C).
It was found that administration of 200 nmol
quinine decreased spike frequency to 77  8%within
30 min ( p < 0.05, Fig. 2). The average amplitude of
epileptiform discharges in the presence of 200 nmol
quinine also decreased to 781  73 mV (p < 0.05,
Fig. 1D). At the 60 min of recording the spike fre-
quency and amplitude were still 63  12% and
83  4%, respectively, below the control values
(Figs. 2 and 3).
Administration of 400 nmol quinine reduced the
mean of spike amplitude from 918  96 to
698  51 mV within 30 min (p < 0.05). The mean
spike frequency was also 44  14% less than control
values at 30 min of recording (p < 0.01, Figs. 1E and
2).
When 1000 nmol quinine was applied to the brain
ventricle, epileptic discharges were more signifi-
cantly decreased. The mean spike frequency was
59  13% less than control values at 30 min after
quinine application ( p < 0.001, Fig. 2). Simulta-
neously, the mean spike amplitude decreased to
562  43 mV (p < 0.01, Fig. 1F).
Two hundred and 400 nmol doses of quinine
caused significant decreases in epileptic behavioral
score at 26  5 and 14  3 min, respectively,
whereas 1000 nmol dose of quinine generated this
effect at 9  4 min (p < 0.05, Table 1).
There were no statistically differences in spike
frequency and amplitude between 200 and 400 nmol
doses of quinine-treated rats (p > 0.05). However,
1000 nmol quinine was more effective than the
other two doses ( p < 0.05).Discussion
In the present study, we examined the anticonvul-
sant properties of quinine, a selective pharmacolo-
gic blocker of Cx36, in penicillin-induced epileptic
activity. This is the first study that demonstrates the
effects of quinine on penicillin-induced generalized
epileptiform activity. According to our findings, qui-
nine significantly decreased epileptic activity in
dose-dependent manner, and this effect was
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Figure 2 The effects of vehicle and quinine (200, 400 and 1000 nmol) on spike frequencies. Zero point shows quinine or
vehicle solution (5% DMSO) injection time. The doses of 200 and 400 nmol quinine significantly decreased the mean spike
frequency of epileptiform activity ( p < 0.05). The 1000 nmol quinine reduced spike frequency more significantly
( p < 0.001). Vehicle solution (5% DMSO) did not change the spike frequency during experiments ( p > 0.05).
Figure 1 The effects of drugs on brain activity. EEG samples on the left represent brain activity prior to drug application
while those on the right show brain activity 30 min after drug administration. Intracerebroventricular injection of
1000 nmol quinine did not change baseline brain activity (A). Injection of penicillin (300 IU) into brain ventricle induces
an epileptiform EEG activity characterized by biphasic spikes and spike-wave complexes (B). Vehicle solution did not
change severity of epileptiform activity (C). Administration of 200 (D), 400 (E) and 1000 nmol (F) quinine significantly
decrease the frequency and amplitude of epileptiform activity. Pen, penicillin.
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Figure 3 Comparison of the effects of vehicle and qui-
nine (200, 400 and 1000 nmol) on spike amplitudes. Zero
point shows quinine or vehicle solution (5% DMSO) injec-
tion time. Intracerebroventricular administration of qui-
nine reduced spike amplitudes in a dose-dependent
manner. Vehicle solution did not change the mean spike
amplitude during experiments.demonstrated via both behavioral observations and
electrophysiological recording method.
Growing evidence indicates that, besides the
chemical synapses, direct coupling via gap junction
channels provides a second major pathway, contri-
buting to normal and abnormal physiological
rhythms in developing and adult brain.24—26 In a
study on suprachiasmatic nucleus neurons, GABA
has been reported to reduce gap junction mediated
communications between these neurons. Research-
ers proposed that this effect of GABA was exerted
via GABAA receptors and the mentioned effect was
probably due to notably increased amounts of Cl
entrance into the cell altering the electrical proper-
ties of the membranes.27 Because of penicillin’s
similar structure to GABA antagonist bicuculline,
in the present study, epilepsy was produced by
crystallized penicillin administration into the brain
ventricle.Table 1 Epileptic behavioral scores in certain minutes in e
Time (min) Vehicle Quinine
200 nm
0 4.4  0.3 4.1  0
5 4.2  0.3 3.9  0
10 4.1  0.4 3.7  0
15 3.9  0.2 3.5  0
30 4.0  0.3 2.8  0
45 3.7  0.4 2.9  0
60 3.6  0.3 2.6  0
75 3.7  0.4 2.4  0
90 3.2  0.3 2.2  0
120 3.1  0.3 1.8  0
*p < 0.05, |p < 0.01.Penicillin model of experimental epilepsy was
utilized by various researchers; nevertheless, most
of these experiments have been performed under
urethane anesthesia.28,29 It was reported that rapid
waves disappeared30 and slow waves began to dom-
inate the brain waves in urethane-anesthetized
rats.31 Therefore, the present study was performed
on fully conscious rats.
Ideal antiepileptic drug should correct the aber-
rant pathophysiology of epileptogenesis without
interfering with physiological neurotransmission.32
According to our findings, quinine did not alter base-
line EEG activity. In the previous in vitro studies, it
has been demonstrated that below a critical concen-
trations threshold, quinine does not influence basic
electrophysiologic parameters and neuronal excit-
ability.20,33 Gajda et al. reported that cortical admi-
nistered quinine (20—40 mM) suppressed the seizure
activity induced by 4-aminopyridine within 5—
6 min.21 In thepresent study, intracerebroventricular
administration of quinine decreased epileptic activ-
ity within 7 min and our findings are consistent with
results of this study.
It is known that convulsant substances increase
transmission in electrical synapses in inverte-
brates.34 The first data regarding direct linking of
gap junctions with epilepsy was reported by Vaquero
et al., who showed, in a morphological analysis, an
increase in astrocytic gap junctions in an experi-
mental model of epilepsy in cats.35 Aronica et al.
demonstrated that mRNAs of Cx36 known to be
major neuronal connexin increased in human epi-
leptic tissues.36
Cx36, the major neuronal Cx, is present predo-
minantly in GABAergic interneurons.13,14 In mice
lacking Cx36, the gamma rhythms are desynchro-
nized both in the cortex and in the hippocam-
pus.14,15 Furthermore, a synchronizing role for
electrical coupling in the spindle frequency
(10 Hz) has been described in the cat reticularach group
ol 400 nmol 1000 nmol
.3 4.2  0.3 4.3  0.2
.3 3.7  0.2 3.5  0.5
.2 3.3  0.2 2.9  0.2 *
.2 2.9  0.3 * 2.7  0.3 *
.3 * 2.7  0.4 * 2.1  0.2 *
.4 * 2.2  0.5 * 1.6  0.2 *
.4 * 2.3  0.3 * 1.5  0.3 *
.3 * 2.1  0.2 * 1.5  0.3 *
.4 * 2.0  0.2 * 1.2  0.2|
.3 * 1.7  0.3 * 1.2  0.2|
Anticonvulsive effects of quinine 171neurons in vivo,37 and it has been suggested that,
because of the low-pass properties of gap junc-
tions,16 they can transmit spikes that can activate
neighboring cells and thus contribute to the propa-
gation and synchronization at low frequencies.16
Spontaneous field inhibitory postsynaptic poten-
tials (IPSPs) and GABAergic ictal-like events reflect
the activity of a gap junction-coupled network of
interneurons. These epileptic activities were com-
pletely and reversibly blocked by both quinine and
as well as its optical isomer quinidine.19 Gajda et al.
also demonstrated antiepileptic effects of quinine
in 4-aminopyridine induced in vivo seizure activ-
ity.21 These findings are supported by the results of
the present study that the uncoupling of Cx36 chan-
nels significantly decreased epileptic activity.
It has been shown that octanol, a non-specific gap
junction blocker, suppresses 4-aminopyridine- and
penicillin-induced seizure activity.21,38 Similarly,
the antiepileptic effect of halothane, another
non-specific gap junction blocker, has been reported
in penicillin model epilepsy.39 Recently, it has been
demonstrated that L-arginine has regulated gap
junctional intercellular coupling via nitric oxide.40
There are also some studies concerning the anti-
epileptic effects of nitric oxide donors.29,41,42 These
reports are consistent with our results.
In conclusion, the presented results in our study
demonstrate that quinine significantly decreased
spike frequencies, spike amplitudes and epileptic
behavioral score in a dose-dependent manner in
penicillin model epilepsy. Quinine may have
decreased the epileptiform activity via preventing
gap junction mediated communication between
neurons. Using of the specific gap junction blockers
in the treatment of epilepsy may contribute to
prevent the propagation and synchronization of
the epileptiform activity. Future experiments are
needed in order to characterize whether or not the
blockade of selective connexins has a similar antic-
onvulsant activity in other animal models.Acknowledgement
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